1. Home
  2. VALN vs GAIN Comparison

VALN vs GAIN Comparison

Compare VALN & GAIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$5.43

Market Cap

536.9M

Sector

Health Care

ML Signal

HOLD

Logo Gladstone Investment Corporation Business Development Company

GAIN

Gladstone Investment Corporation Business Development Company

HOLD

Current Price

$16.64

Market Cap

646.9M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
GAIN
Founded
2012
2005
Country
France
United States
Employees
N/A
70
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Finance: Consumer Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
536.9M
646.9M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VALN
GAIN
Price
$5.43
$16.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$15.50
$14.75
AVG Volume (30 Days)
92.8K
330.0K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
9.19%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$9.07
Revenue Next Year
$93.87
$7.32
P/E Ratio
N/A
$4.38
Revenue Growth
N/A
N/A
52 Week Low
$5.15
$13.14
52 Week High
$12.25
$16.94

Technical Indicators

Market Signals
Indicator
VALN
GAIN
Relative Strength Index (RSI) 29.03 75.42
Support Level $5.15 $13.55
Resistance Level $6.42 N/A
Average True Range (ATR) 0.25 0.37
MACD 0.10 0.05
Stochastic Oscillator 18.11 84.02

Price Performance

Historical Comparison
VALN
GAIN

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About GAIN Gladstone Investment Corporation Business Development Company

Gladstone Investment Corp operates as an externally managed, closed-end, non-diversified management investment company. Its objective is to invest in debt and equity securities of established private businesses operating in the U.S. and to achieve and grow current income by investing in debt securities of established businesses; provide the stockholders with long-term capital appreciation in the value of its assets by investing in equity securities of established businesses. It focuses on investing in lower-middle-market private businesses.

Share on Social Networks: